2017
DOI: 10.1111/eip.12444
|View full text |Cite
|
Sign up to set email alerts
|

Influence of demographic characteristics on attenuated positive psychotic symptoms in a young, help‐seeking, at‐risk population

Abstract: Our results highlighted the role of age and, thereby, neurodevelopment in psychosis-risk assessment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 28 publications
0
7
0
Order By: Relevance
“…Moderate influences of sex, age, and, largely explained by age, education years on APS/BIPS have also been reported from a Swiss patient sample (Theodoridou et al 2017 ). Moreover, a recent review on the impact of cannabis as the most commonly used drug reinforced its role in the development of psychotic and schizotypal symptoms, with family history and traumatic events likely increasing sensitivity to cannabis (Løberg et al 2014 ).…”
Section: Discussionmentioning
confidence: 64%
“…Moderate influences of sex, age, and, largely explained by age, education years on APS/BIPS have also been reported from a Swiss patient sample (Theodoridou et al 2017 ). Moreover, a recent review on the impact of cannabis as the most commonly used drug reinforced its role in the development of psychotic and schizotypal symptoms, with family history and traumatic events likely increasing sensitivity to cannabis (Løberg et al 2014 ).…”
Section: Discussionmentioning
confidence: 64%
“…In light of these considerations that may have major impact on future research into the neurobiological underpinnings of symptoms of psychosis (15,31) and the future development of both age-adapted early detection and age-adapted early interventions (6,12,31), and in light of the limited studies on age effects on BS, we investigated the age effects on and age thresholds of BS in a CHR sample. In line with the replication of age effects on APS in clinical samples (23,25), we expected that age thresholds would follow those earlier reported from the Swiss community study (29,31). Additionally, in light of the moderating effect of age on the association of BS with functional impairment, which was weaker in younger subjects (29,31), we also examined if the effect of age on BS might be influenced by the presence of functional impairments.…”
Section: Introductionmentioning
confidence: 68%
“…Next to this lower psychosis-predictive value of CHR criteria in children and younger adolescents, in particular of the APS syndrome (14,21), accumulating evidence suggests that age and developmental aspects might also alter the general clinical relevance and the prevalence rate of CHR symptoms. Again, this evidence has mainly accumulated for APS and BLIPS (13,14,(21)(22)(23)(24)(25)(26)(27)(28), in doing so indicating an age threshold around the age of 16 below which these symptoms are more frequent, but less clinically relevant in terms of their association with functional deficits and/or nonpsychotic mental disorder, and less psychosis-predictive (21-23, 28, 29). In doing so, the interaction of APS with age played a particular role in predicting psychosocial functioning, with APS being increasingly associated with functional deficits with advancing age in the community (29).…”
Section: Introductionmentioning
confidence: 99%
“…We had chosen this age group because higher nonconversion rates compared to adult samples were reported for this group[ 19 , 21 ], and because CHR symptoms and criteria were shown to be more prevalent and less clinically relevant in children and adolescents[ 22 , 23 , 51 - 53 ]. Consequently, we expected that CHR symptoms and criteria would most likely show characteristics indicative of a pluripotent syndrome, of a transdiagnostic risk factor or of a severity marker in this age group.…”
Section: Discussionmentioning
confidence: 99%
“…Both community and clinical studies on the effect of age on CHR symptoms and criteria indicated an age threshold around age of 16 years for APS and BIPS, with perceptual APS/BIPS being more prevalent below this age and all APS/BIPS being less clinically relevant[ 22 , 23 , 51 , 53 ]. For perceptual and cognitive basic symptoms, the age thresholds for prevalence and clinical significance were around age of 18 and 23 years, respectively[ 23 , 52 ].…”
Section: Discussionmentioning
confidence: 99%